Glaukos Corporation (GKOS) Dividend History

Glaukos Corporation (GKOS) is a medical device company that specializes in innovative treatments for glaucoma, corneal disorders, and other ocular diseases. It is known for its development of minimally invasive devices, including the iStent trabecular micro-bypass stent, which helps lower intraocular pressure and reduces reliance on medication for glaucoma patients. The company focuses on advancing ophthalmic healthcare through novel, minimally invasive surgical solutions.

1 Glaukos Way, Aliso Viejo, CA, 92656
Phone: 949-367-9600
Website: https://www.glaukos.com

Dividend History

Glaukos Corporation currently does not pay dividends

Company News

Glaukos Stocks Rides on Strong Product Demand Amid Competition

Glaukos Corporation is focused on developing and commercializing surgical devices and pharmaceutical therapies for glaucoma treatment. The company's iStent product line and global glaucoma and Corneal Health franchises are performing well, despite competition and supply chain challenges. Glaukos is also advancing its pipeline, including iDose TREX, iDose ROCK, and iLution Travoprost.

Benzinga

Featured Companies: BSX DGX
Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings? - Zacks Investment Research

Boston Scientific Corporation is scheduled to report its Q2 2024 results on July 24. The company is expected to report revenue growth of around 11.7% and adjusted earnings of 58 cents per share. However, the company may face challenges from a challenging supply environment, rising costs, and healthcare staffing shortages.

Zacks Investment Research

Featured Companies: BSX EYE TNDM
Truist lifts Glaukos shares target, highlights strong market position - Investing.com

Truist Securities has raised its price target for Glaukos Corporation shares to $141, citing the company's strong market position and the potential of its iDose product. The firm maintains a Buy rating on the stock.

Investing.com
This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga

Top Wall Street analysts have downgraded their ratings on several companies, including Spotify, Visa, Helen of Troy, LegalZoom, and Glaukos, citing various reasons for their bearish outlook.

Benzinga

Featured Companies: HELE LZ SPOT V
Global Ophthalmic Devices Market Analysis Report 2024-2032 Featuring Johnson & Johnson, Topcon, Canon, Alcon ... - GlobeNewswire

The global ophthalmic devices market is projected to grow from $6.79 billion in 2023 to $10.22 billion by 2032, driven by the increasing prevalence of eye conditions and technological advancements in diagnosis and treatment.

GlobeNewswire Inc.

Featured Companies: ALC JNJ STAA

Dividend data last updated 06/07/2025 20:09:59 UTC